Antidepressants and antipsychotics classified with torsades de pointes arrhythmia risk and mortality in older adults - a Swedish nationwide study

被引:50
作者
Danielsson, Bengt [1 ]
Collin, Julius [1 ]
Bergman, Gudrun Jonasdottir [1 ]
Borg, Natalia [1 ]
Salmi, Peter [1 ]
Fastbom, Johan [1 ,2 ,3 ]
机构
[1] Natl Board Hlth & Welf Socialstyrelsen, Dept Anal & Evaluat, S-10630 Stockholm, Sweden
[2] Karolinska Inst, Aging Res Ctr, Gavlegatan 16, S-11330 Stockholm, Sweden
[3] Stockholm Univ, Gavlegatan 16, S-11330 Stockholm, Sweden
关键词
all-cause mortality; antidepressants; antipsychotics; elderly; torsades de pointes; QTC INTERVAL PROLONGATION; SUDDEN CARDIAC DEATH; PSYCHOTROPIC-DRUGS; CLARITHROMYCIN; CITALOPRAM; RESIDENTS; DEMENTIA; CHANNELS; PEOPLE;
D O I
10.1111/bcp.12829
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
AimThe aim of the study was to examine mortality risk associated with use of antidepressants and antipsychotics classified with torsades de pointes (TdP) risk in elderly. MethodsA matched case-control register study was conducted in people 65 years and older dying outside hospital from 2008-2013 (n=286092) and matched controls (n=1430460). The association between prescription of antidepressants and antipsychotics with various TdP risk according to CredibleMeds () and all-cause mortality was studied by multivariate conditional logistic regression adjusted for comorbidity and several other confounders. ResultsUse of antidepressants classified with known or possible TdP risk, was associated with higher adjusted risk for mortality (OR 1.53, 95% CI 1.51, 1.56 and OR 1.63, 95% CI 1.61, 1.67, respectively) compared with antidepressants classified with conditional TdP risk (OR 1.25, 95% CI 1.22, 1.28) or without TdP classification (OR 0.99, 95% CI 0.94, 1.05). Antipsychotics classified with known TdP risk were associated with higher risk (OR 4.57, 95% CI 4.37, 4.78) than antipsychotics with possible risk (OR 2.58, 95% CI 2.52, 2.64) or without TdP classification (OR 2.14, 95% CI 2.03, 2.65). The following risk ranking was observed for commonly used antidepressants: mirtazapine > citalopram > sertraline > amitriptyline and for antipsychotics: haloperidol > risperidone >olanzapine > quetiapine. ConclusionThe CredibleMeds system predicted drug-associated risk for mortality in the elderly at the risk class level. Among antipsychotics, haloperidol, and among antidepressants, mirtazapine and citalopram, were associated with the highest risks. The results suggest that the TdP risk with antidepressants and antipsychotics should be taken into consideration when prescribing to the elderly.
引用
收藏
页码:773 / 783
页数:11
相关论文
共 51 条
  • [41] Skoogh J, 2015, THESIS LUND U
  • [42] Thanacoody H K Ruben, 2005, Toxicol Rev, V24, P205, DOI 10.2165/00139709-200524030-00013
  • [43] Clarithromycin, QTc interval prolongation and torsades de pointes: the need to study case reports
    Vieweg, W. Victor R.
    Hancox, Jules C.
    Hasnain, Mehrul
    Koneru, Jayanthi N.
    Gysel, Michael
    Baranchuk, Adrian
    [J]. THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2013, 1 (04) : 121 - 138
  • [44] Citalopram, QTc Interval Prolongation, and Torsade de Pointes. How Should We Apply the Recent FDA Ruling?
    Vieweg, W. Victor R.
    Hasnain, Mehrul
    Howland, Robert H.
    Hettema, John M.
    Kogut, Christopher
    Wood, Mark A.
    Pandurangi, Ananda K.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2012, 125 (09) : 859 - 868
  • [45] The prevalence of mental disorders in older people in Western countries - a meta-analysis
    Volkert, Jana
    Schulz, Holger
    Haerter, Martin
    Wlodarczyk, Olga
    Andreas, Sylke
    [J]. AGEING RESEARCH REVIEWS, 2013, 12 (01) : 339 - 353
  • [46] Drug Treatment in Older People before and after the Transition to a Multi-Dose Drug Dispensing System-A Longitudinal Analysis
    Wallerstedt, Susanna M.
    Fastbom, Johan
    Johnell, Kristina
    Sjoberg, Christina
    Landahl, Sten
    Sundstrom, Anders
    [J]. PLOS ONE, 2013, 8 (06):
  • [47] QTc Prolongation by Psychotropic Drugs and the Risk of Torsade de Pointes
    Wenzel-Seifert, Katharina
    Wittmann, Markus
    Haen, Ekkehard
    [J]. DEUTSCHES ARZTEBLATT INTERNATIONAL, 2011, 108 (41): : 687 - U11
  • [48] The new Swedish Prescribed Drug Register -: Opportunities for pharmacoepidemiological research and experience from the first six months
    Wettermark, Bjorn
    Harnmar, Niklas
    MichaelFored, C.
    Leimanis, Andrejs
    Olausson, Petra Otterblad
    Bergman, Ulf
    Persson, Ingemar
    Sundstrom, Anders
    Westerholm, Barbro
    Rosen, Mans
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (07) : 726 - 735
  • [49] Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment
    Wisniowska, Barbara
    Mendyk, Aleksander
    Fijorek, Kamil
    Glinka, Anna
    Polak, Sebastian
    [J]. JOURNAL OF APPLIED TOXICOLOGY, 2012, 32 (10) : 858 - 866
  • [50] Psychotropic drugs, cardiac arrhythmia, and sudden death
    Witchel, HJ
    Hancox, JC
    Nutt, DJ
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2003, 23 (01) : 58 - 77